Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Neuron|December 15, 2010
Capturing VCP: another molecular piece in the ALS jigsaw puzzleChristopher E ShawBiomedicines|June 2, 2021
Disease Mechanisms and Therapeutic Approaches in <i>C9orf72</i> ALS-FTDKeith Mayl, Christopher E Shaw, Youn-Bok LeeNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 6, 2015
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic TargetsEmma L Scotter, Han-Jou Chen, Christopher E ShawNeurobiology of Disease|January 16, 2014
Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivoVineeta Bhasker Tripathi, Pranetha Baskaran, Christopher E Shaw, et al.Acta Neuropathologica|December 25, 2013
Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementiaAlan Stepto, Jean-Marc Gallo, Christopher E Shaw, et al.Stem Cell Research|February 20, 2021
Generation of six induced pluripotent stem cell lines from patients with amyotrophic lateral sclerosis with associated genetic mutations in either FUS or ANXA11Erin C Hedges, Simon Topp, Christopher E Shaw, et al.Genes|May 27, 2023
Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease ModellingErin C Hedges, Graham Cocks, Christopher E Shaw, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2012
pNfH is a promising biomarker for ALSJeban Ganesalingam, Jiyan An, Robert Bowser, et al.Frontiers in Neuroscience|June 20, 2019
Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar DegenerationWejdan Kattuah, Boris Rogelj, Andrew King, et al.Journal of Neurochemistry|March 23, 2011
Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALSJeban Ganesalingam, Jiyan An, Christopher E Shaw, et al.Pageof 20